Peptide Referee

Cardiogen: research, legal status and who sells it

This page is information, not medical advice. Cardiogen is not approved as a medicine in the markets below unless stated. We don't publish dosing or usage instructions.

Also known as
Ala-Glu-Asp-Arg, AEDR peptide
Category
Synthetic tetrapeptide (Khavinson peptide bioregulator)
Evidence level
Preclinical (lab and animal studies)
Price range
$1.25/mg to $5.25/mg, median $2.75/mg across 19 vendors (compare)
Our lab tests
None yet (how testing will work)
WhereStatus
United StatesNo FDA-approved drug contains the cardiogen peptide; CardioGen-82, an FDA-approved rubidium Rb-82 product with a similar name, is unrelated [1][2].
United KingdomNo UK-licensed medicine containing cardiogen appears in the MHRA products database [3].
European UnionNo medicine containing the cardiogen peptide is authorized in the EU; EMA's Article 57 data list only an unrelated rubidium-82 product named Cardiogen [4][5].
CanadaNo product containing cardiogen appears in Health Canada's Drug Product Database [6].
AustraliaCardiogen is not named in Australia's Poisons Standard (October 2026) [7].
Sport (WADA)Not named on the 2026 Prohibited List; its section S0 bans any pharmacological substance with no current approval for human therapeutic use [8].
 Summaries of official sources, checked —. Rules change; follow the source links. Not legal advice.

We haven't published a full overview of Cardiogen yet. The legal status table and live prices on this page are current.

Cardiogen prices: cheapest listings

The five lowest $/mg listings out of 20. See all Cardiogen prices

Vendor Transparency Product Size Price $/mg vs median Stock Vendor's page
Bulk Peptide Wholesale 45/100* Cardiogen 20 mg (10 vials) 20 mg × 10 $250 $1.25/mg −55% In stock View
Bulk Peptide Supply 57/100* Cardiogen 20 mg 20 mg $33 $1.63/mg −41% In stock View
Welli Labs 10/100* Cardiogen 25mg 25 mg $44 $1.76/mg −36% In stock View
Bulk Peptide Supply 57/100* Cardiogen 20 mg (10 vials) 20 mg × 10 $375 $1.88/mg −32% In stock View
Peptide Crafters 27/100* CARDIOGEN (25mg) 25 mg $55 $2.20/mg −20% In stock View

Prices come from each vendor's public product feed and were last fetched Oct 15, 2026. They exclude shipping and discounts. $/mg uses the labeled amount, not measured content. A transparency score marked * is based on fewer than six checks; checks we couldn't complete score 0. How we compare prices.

Sources

  1. Drugs@FDA: FDA-Approved Drugs (database searched by active ingredient). U.S. Food and Drug Administration. Accessed Oct 15, 2026
  2. Drugs@FDA: NDA 019414 (CardioGen-82, rubidium chloride Rb-82; an unrelated product). U.S. Food and Drug Administration. Accessed Oct 15, 2026
  3. MHRA Products: licensed-medicine search for "cardiogen". Medicines and Healthcare products Regulatory Agency (UK). Accessed Oct 15, 2026
  4. EMA medicines data: centrally authorised human medicines (export of 14 October 2026). European Medicines Agency. Accessed Oct 15, 2026
  5. EMA Article 57 product data: medicines authorised in the EU/EEA (data as of 9 October 2026). European Medicines Agency. Accessed Oct 15, 2026
  6. Drug Product Database online query (searched by active ingredient). Health Canada. Accessed Oct 15, 2026
  7. Therapeutic Goods (Poisons Standard—October 2026) Instrument 2026 (F2026L01327, registered 30 September 2026). Federal Register of Legislation, Australian Government. Accessed Oct 15, 2026
  8. World Anti-Doping Code International Standard: Prohibited List 2026 (in force 1 January 2026). World Anti-Doping Agency. Accessed Oct 15, 2026
  9. Transport of Biologically Active Ultrashort Peptides Using POT and LAT Carriers. International Journal of Molecular Sciences (2022). Accessed Oct 15, 2026
  10. Tetrapeptide H-Ala-Glu-Asp-Arg-OH stimulates expression of cytoskeletal and nuclear matrix proteins. Bulletin of Experimental Biology and Medicine (2012). Accessed Oct 15, 2026